A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients

NCT00971893 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-11-29

No results posted yet for this study

Summary

The present study is designed to collect data on real world experience on use of Medrol in acute asthma in Indian patients.

Conditions

Interventions

DRUG

Oral Methylprednisolone Tablets

Oral Methylprednisolone tablets given as per locally approved prescribing information

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-04-30
Completion
2010-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00971893 on ClinicalTrials.gov